CBL E3 ubiquitin ligases were found as key target associated to the regulation of central T-cell dysfunctional pathways in T-cell lines and in primary T cells from non-small cell lung cancer (NSCLC) patients. Here, CBL is linked to non-small cell lung carcinoma.